<iframe src="https://www.googletagmanager.com/ns.html?id=GTM-NWS6QFW" height="0" width="0" style="display:none;visibility:hidden">

Tactics for Agile in Biopharma Research & Development

Posted by EG Life Sciences
A director of product management shares what works and what doesn't when implementing Agile within drug discovery organizations. Learn more today.

Read More »

Waterfall or Agile: Wrong Question!

Posted by Bob Ellis
Eliassen Group's Bob Ellis shares how to reframe your Agile approach. Start by empathizing with the audience, not focusing on a solution. Learn more.

Read More »

The Future of Biotech and Pharma Manufacturing

Posted by Sandra Acosta
Follow Sandra Acosta, Director of Biopharma Solutions for EG Life Sciences, as she considers what's next for these two major industries.

Read More »

Scrumming Scientific Project Management

Posted by EG Life Sciences
Scientist and Agilist Kendra West shares tips for introducing Agile practices within scientific project management. Learn from her findings today.

Read More »

Pharmaceutical Innovation and Agility

Posted by EG Life Sciences
Dr. Terry Barnhart shares how your company can boost innovation through Agile pharmaceuticals. Start accelerating your innovation today.

Read More »

Behind the Scenes: The Production of Viral Vector Vaccines

Posted by Sandra Acosta
Have you ever wondered what goes into the production of viral vector vaccines? Read on.

Read More »

What are Viral Vectors and How Do They Work?

Posted by Sandra Acosta
In this blog post, Sandra Acosta answers timely questions in the life sciences space: What are viral vectors? And how do the types of viral vectors work?

Read More »

Cell Gene Therapy and Viral Vectors: How Can They Be Effective for Compromising Diseases and COVID-19?

Posted by Sandra Acosta
With new technologies like cell gene therapy and viral vectors, we have a better chance of beating COVID-19 and serious diseases. Learn more here.

Read More »

Automation for Continuous Compliance in BioPharma and Life Sciences

Posted by Jim Damato
Eliassen Group experts talk about the impact of automation on continuous compliance, which can lead to savings and an improvement in outcomes.

Read More »

Viral Controls and Prevention of Cross-Contamination in the Vaccine Industry

Posted by Sandra Acosta
Sandra Acosta shares the steps that industries can follow to improve safety within the vaccine industry. Read more.

Read More »

Celebrating Eliassen Group’s Brand Evolution and Expanded Service Offerings

Posted by EG Life Sciences
EG Life Sciences is sharing the news of Eliassen Group’s updated brand. Read more about what this means for us – and our clients.

Read More »

Sources of Cross-Contamination in Vaccine Production

Posted by Sandra Acosta
In the vaccine production process, protecting against foreign matter is crucial. Learn about sources of contamination in vaccines so you can avoid them.

Read More »

What if Continuous Compliance were possible in the Drug Industry?

Posted by Jennifer Mariani
Jennifer Mariani discusses the resistance to change in the heavily-regulated drug industry and proposes Agile and Continuous Compliance as the solution.

Read More »

EU IVDR Requirements for Certification

Posted by EG Life Sciences
Most IVD manufacturers are taking the necessary steps to prepare to comply with the IVDR. Are you ready to meet the IVDR requirements for Certification?

Read More »

Is Agile the Answer to Big Pharma's Digital Revolution?

Posted by Jennifer Mariani
A push for speed and innovation is forcing large pharma companies to exchange less-efficient liner, traditional processes for methodologies like Agile.

Read More »

Subscribe to our Blog